首页> 美国卫生研究院文献>Cells >Noninvasive Tracking of Hematopoietic Stem Cells in a Bone Marrow Transplant Model
【2h】

Noninvasive Tracking of Hematopoietic Stem Cells in a Bone Marrow Transplant Model

机译:骨髓移植模型中造血干细胞的非侵入性追踪

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The hematopoietic stem cell engraftment depends on adequate cell numbers, their homing, and the subsequent short and long-term engraftment of these cells in the niche. We performed a systematic review of the methods employed to track hematopoietic reconstitution using molecular imaging. We searched articles indexed, published prior to January 2020, in PubMed, Cochrane, and Scopus with the following keyword sequences: (Hematopoietic Stem Cell OR Hematopoietic Progenitor Cell) AND (Tracking OR Homing) AND (Transplantation). Of 2191 articles identified, only 21 articles were included in this review, after screening and eligibility assessment. The cell source was in the majority of bone marrow from mice (43%), followed by the umbilical cord from humans (33%). The labeling agent had the follow distribution between the selected studies: 14% nanoparticle, 29% radioisotope, 19% fluorophore, 19% luciferase, and 19% animal transgenic. The type of graft used in the studies was 57% allogeneic, 38% xenogeneic, and 5% autologous, being the HSC receptor: 57% mice, 9% rat, 19% fish, 5% for dog, porcine and salamander. The imaging technique used in the HSC tracking had the following distribution between studies: Positron emission tomography/single-photon emission computed tomography 29%, bioluminescence 33%, fluorescence 19%, magnetic resonance imaging 14%, and near-infrared fluorescence imaging 5%. The efficiency of the graft was evaluated in 61% of the selected studies, and before one month of implantation, the cell renewal was very low (less than 20%), but after three months, the efficiency was more than 50%, mainly in the allogeneic graft. In conclusion, our review showed an increase in using noninvasive imaging techniques in HSC tracking using the bone marrow transplant model. However, successful transplantation depends on the formation of engraftment, and the functionality of cells after the graft, aspects that are poorly explored and that have high relevance for clinical analysis.
机译:造血干细胞的植入取决于适当的细胞数量,它们的归巢以及这些细胞随后在利基中的短期和长期植入。我们对使用分子成像追踪造血重建的方法进行了系统的综述。我们用以下关键词序列搜索了在2020年1月之前发表在PubMed,Cochrane和Scopus上的索引文章:(造血干细胞或造血祖细胞)和(追踪或归巢)和(移植)。经筛选和资格评估后,在鉴定的2191篇文章中,只有21篇文章被纳入本评价。细胞来源大部分来自小鼠的骨髓(43%),其次是人类的脐带(33%)。在选定的研究之间,标记剂具有以下分布:14%的纳米颗粒,29%的放射性同位素,19%的荧光团,19%的荧光素酶和19%的动物转基因。研究中使用的移植物类型为:57%的同种异体,38%的异种和5%的自体,是HSC受体:57%的老鼠,9%的老鼠,19%的鱼,5%的狗,猪和sal。在HSC跟踪中使用的成像技术在研究之间具有以下分布:正电子发射断层扫描/单光子发射计算机断层扫描29%,生物发光33%,荧光19%,磁共振成像14%和近红外荧光成像5% 。在选定的研究中有61%对移植物的效率进行了评估,并且在植入一个月前,细胞更新非常低(不到20%),但是在三个月后,效率超过50%,主要是在同种异体移植。总之,我们的审查显示在使用骨髓移植模型的HSC追踪中使用无创成像技术的情况有所增加。然而,成功的移植取决于移植物的形成以及移植后细胞的功能性,这些方面的探索不足,并且与临床分析具有高度相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号